Two people breathe the same smoggy air, eat the same grilled food, or take the same medication, and one seems to shake it off while the other feels sluggish or foggy for days. Your body’s ability to break down and clear out everyday chemical exposures, called xenobiotics, isn’t identical from person to person, and genetics is a real part of why, alongside diet, liver and kidney health, and how much exposure you’re actually getting. One relevant gene is GSTM1, part of the glutathione S-transferase family responsible for neutralizing many environmental toxins. A common deletion of this gene, found in roughly 40 to 58% of people depending on ancestry, results in a complete loss of that particular enzyme’s activity (Micheli et al., 2010). This is one contributing factor among several, not a full explanation for how anyone’s body handles daily exposures.
GSTM1 and GSTT1: Missing Enzymes, Not Just Weak Ones
Unlike many genetic variants that simply dial an enzyme’s activity up or down, GSTM1 and GSTT1 have a “null” version that represents a complete deletion of the gene. People with this null genotype don’t have a weaker version of the enzyme; they have none of it at all.
How Common Is This, Really?
These null genotypes are surprisingly common and vary widely by ancestry. The GSTM1-null genotype affects an estimated 43 to 58% of people across various populations, while GSTT1-null ranges from about 20% in African-American populations to over 60% in Chinese and Korean populations (Micheli et al., 2010). Because these genes normally help neutralize byproducts of oxidative stress and various environmental compounds, having both null simultaneously means relying more heavily on other detox pathways to pick up the slack.
What the Research Actually Links This To
Studies have connected these null genotypes to modestly higher risk for a range of conditions tied to oxidative stress and toxin exposure, including type 2 diabetes in a Brazilian cohort, where the GSTT1-null genotype specifically was associated with a more than threefold increase in risk (Amaral et al., 2013), though the same study found no such association for GSTM1 alone, and other populations have shown inconsistent results for both genes. This variability is a useful reminder that carrying a null genotype shifts probability rather than determining outcome.
NAT2 and How Fast You Process Certain Chemicals
N-acetyltransferase 2 (NAT2) detoxifies a wide range of compounds by attaching an acetyl group to them, making them easier for the body to excrete. This includes certain environmental carcinogens, some medications like the tuberculosis drug isoniazid, and compounds found in cigarette smoke and grilled food.
Variants in NAT2 sort people into slow, intermediate, or rapid acetylator categories, and this trait shows striking population-level variation shaped by historical diet. Researchers studying Central Asian populations found that slow-acetylator NAT2 variants were more common in long-term agricultural populations than in nomadic pastoralist groups, suggesting the shift to farming thousands of years ago actually changed the selective pressures on this gene (Sabbagh et al., 2008). Slow acetylators process certain drugs and environmental compounds more gradually, which can mean higher exposure to those compounds’ effects over the same timeframe as someone with a faster-acetylating version of the gene.
NQO1 and Cellular Defense Against Oxidative Stress
NQO1 produces an enzyme that neutralizes reactive quinone compounds before they can cause cellular damage, and it’s tightly controlled by the same master antioxidant switch, called Nrf2, that regulates hundreds of other protective genes in the body. A common variant (C609T) reduces the enzyme’s activity by affecting how well it binds its necessary cofactor.
This variant has been linked to increased lung cancer risk in case-control research (Sunaga et al., 2006) and to greater oxidative damage markers in pesticide-exposed agricultural workers (Mansour et al., 2018). But it’s worth noting this gene doesn’t predict everything oxidative-stress-related equally well: a separate study specifically testing this same variant against multiple sclerosis risk found no significant association at all (Fernandez et al., 2014), despite earlier research in a different population suggesting otherwise.
What Matters Beyond Genetics
Actual exposure levels matter enormously, and reducing them, through better ventilation, air filtration, minimizing char on grilled foods, and avoiding unnecessary chemical exposures, benefits everyone regardless of genotype. Liver health, hydration, sleep, and adequate intake of nutrients that support these detox pathways, like the amino acids that make glutathione, all influence how well these systems function day to day. No gene variant discussed here is a diagnosis or a reason for alarm; they’re modest pieces of a much larger, mostly environmental picture.
Where Genetic Testing Fits In
If you’ve wondered why environmental exposures seem to affect you more than people around you, a detox pathway genetic report can walk through markers like these and how they fit together. It’s meant to build understanding, not to diagnose a condition or replace medical care.
Frequently Asked Questions
If I have the GSTM1-null genotype, do I need a special detox program?
No. This genotype is extremely common and most carriers have no related health issues. Supporting general liver health through diet, sleep, and reduced toxin exposure benefits everyone regardless of genotype.
Does slow NAT2 acetylation mean I should avoid certain medications?
Any medication concerns should be discussed with your doctor or pharmacist, who can consider your specific situation rather than genetics alone.
Can I improve these enzymes’ activity through diet?
Some nutrients support the pathways these genes are part of, but genetic variants themselves cannot be changed through diet. Diet can support overall detoxification capacity regardless of your specific genotype.
